Transaction in Own Shares

Summary by AI ^BETAClose X

SThree plc has announced the purchase of 326,811 of its ordinary shares between March 19th and March 25th, 2026, through Investec Bank plc. The volume-weighted average price paid across these transactions ranged from 147.81 pence to 160.95 pence per share, with the lowest price paid being 144.00 pence and the highest 162.20 pence. The company intends to cancel these repurchased shares.

Disclaimer*

SThree plc

27 March 2026

27^th March 2026

SThree plc

("SThree" or the "Company")

Transaction in Own Shares

The Company announces today it has purchased the following number of its ordinary shares of 1 pence each ("Ordinary Shares") through Investec Bank plc in the period from 19th March 2026 to 25th March 2026.

Date	Venue	Volume-weighted average price (p)	Aggregated volume	Lowest price per share (p)	Highest price per share (p)
19 March 2026	XLON	160.9517	60,711	154.8000	162.2000
20 March 2026	XLON	155.3870	67,774	152.8000	156.6000
23 March 2026	XLON	149.6539	63,018	147.8000	154.8000
24 March 2026	XLON	150.3346	66,899	147.6000	151.6000
25 March 2026	XLON	147.8065	69,209	144.0000	149.6000

The Company intends to cancel the purchased shares.

Schedule of Purchases - Individual Transactions

In accordance with Article 5(1)(b) of the Market Abuse Regulation (EU) No 596/2014 as it forms part of UK law, a full breakdown of the individual trades made by the Investec Bank on behalf of the Company as part of the buyback programme is attached to this announcement.

http://www.rns-pdf.londonstockexchange.com/rns/2818Y_1-2026-3-26.pdf

For further information please contact:

SThree plc
Timo Lehne, CEO Andrew Beach, CFO Charlie Hildesley, Investor Relations Manager	via Alma
Alma Strategic Communications	+44 20 3405 0205
Rebecca Sanders-Hewett Hilary Buchanan Sam Modlin Rose Docherty	SThree@almastrategic.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END